scispace - formally typeset
I

Iván Gallegos

Researcher at University of Chile

Publications -  30
Citations -  471

Iván Gallegos is an academic researcher from University of Chile. The author has contributed to research in topics: Cancer & Metastasis. The author has an hindex of 10, co-authored 27 publications receiving 347 citations.

Papers
More filters
Journal ArticleDOI

Proapoptotic effect of endocannabinoids in prostate cancer cells.

TL;DR: It is suggested that endocannabinoids may be a beneficial option for the treatment of prostate cancer that has become nonresponsive to common therapies.
Journal ArticleDOI

The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and β-catenin, in prostate cancer

TL;DR: Changes in expression and cell distribution of E-cadherin and beta-catenin correlated with the progression degree of prostate adenocarcinoma, suggesting a role of these molecules as markers of progression and prognosis.
Journal ArticleDOI

Molecular signature of cancer stem cells isolated from prostate carcinoma and expression of stem markers in different Gleason grades and metastasis.

TL;DR: It is suggested that the CSCs in PCa reach an important number in medium Gleason grades, when the tumor is still confined into the gland, and may be a prognosis factor for PCa recurrence.
Journal ArticleDOI

Increased SNAIL expression and low syndecan levels are associated with high Gleason grade in prostate cancer

TL;DR: Analyzing immunochemically the expression of SNAIL, syndecans 1 and 2 and other EMT markers in a tissue microarray of PC samples and PC cell lines concluded that increased SNAil levels in advanced PC are associated with low expression of syndecan 1.
Journal ArticleDOI

Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer

TL;DR: Evaluated the feasibility of producing effective dendritic cell (DC) based vaccines using heat-conditioned cell lysates derived from gallbladder cancer cell lines (GBCCL) and found that they expressed some tumor-associated antigens such as CEA, MUC-1, CA19-9, Erb2, Survivin, and several carcinoembryonicAntigens.